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Purine-rich enhancers function in the AT-AC
pre-mRNA splicing pathway and do so
independently of intact U1 snRNP
QIANG WU1 and ADRIAN R. KRAINER
Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA, and Program in Molecular and Cellular
Biology, State University of New York at Stony Brook, Stony Brook, New York 11794, USA
ABSTRACT
A rare class of introns in higher eukaryotes is processed by the recently discovered AT-AC spliceosome. AT-AC
introns are processed inefficiently in vitro, but the reaction is stimulated by exon-definition interactions involving
binding of U1 snRNP to the 59 splice site of the downstream conventional intron. We report that purine-rich exonic
splicing enhancers also strongly stimulate sodium channel AT-AC splicing. Intact U2, U4, or U6 snRNAs are not
required for enhancer function or for exon definition. Enhancer function is independent of U1 snRNP, showing that
splicing stimulation by a downstream 59 splice site and by an exonic enhancer differ mechanistically.
Keywords: AT-AC intron; exon definition; exonic splicing enhancer (ESE); pre-mRNA splicing; U1 snRNP
INTRODUCTION
AT-AC splicing is catalyzed by a minor spliceosome
with at least four snRNA constituents distinct from those
present in the major spliceosome (reviewed in Nilsen,
1998)+AT-AC introns were first recognized on the basis
of their distinctive splice-site consensus sequences
(Jackson, 1991)+ Initially, only four examples of phylo-
genetically conserved AT-AC introns were found in ver-
tebrate or invertebrate genes (Hall & Padgett, 1994;
Tarn & Steitz, 1996a)+ More recently, extensive se-
quence compilations showed that AT-AC introns are
more abundant and are present in all higher eukary-
otes (Sharp & Burge, 1997; Tarn & Steitz, 1997; Wu &
Krainer, 1997)+ The U12 snRNA was recently shown to
be essential for AT-AC splicing both in vivo (Hall &
Padgett, 1996) and in vitro (Tarn & Steitz, 1996a; Wu &
Krainer, 1996)+ The U11 snRNA is present in splice-
osomes assembled in vitro (Tarn & Steitz, 1996a) and
can be crosslinked to an AT-AC intron 59 splice site (Yu
& Steitz, 1997)+ U11 was also shown to base pair with
an AT-AC intron 59 splice site in vivo (Kolossova &
Padgett, 1997)+ These findings confirmed the predicted
roles of U11 and U12 snRNAs (Hall & Padgett, 1994)+
The U4atac and U6atac snRNAs, two novel snRNAs
isolated from an in vitro-assembled AT-AC spliceosome,
were shown to be essential for processing of the AT-AC
intron of proliferating cell nucleolar antigen (P120) in
vitro (Tarn & Steitz, 1996b)+ These two snRNAs are
also essential for in vitro splicing of an AT-AC intron in
the voltage-gated skeletal muscle sodium channel a
subunit (SCN4A) pre-mRNA (Wu & Krainer, 1997)+ Re-
cently, U6atac was shown to recognize the AT-AC 59
splice site by base pairing in vivo (Incorvaia & Padgett,
1998)+
In the major splicing pathway, the pre-mRNA cis-
acting signals that help define the correct exon–intron
boundaries include the 59 splice site, 39 splice site, and
branch site elements, as well as exonic or intronic splic-
ing enhancer or silencer elements (reviewed in Black,
1995)+ Individual signals are degenerate in sequence,
but collectively they allow precise removal of introns by
the spliceosome+ Accurate splicing appears to require
a fine balance between intrinsic splice-site strengths
and modulation by the auxiliary elements that surround
the splice sites, especially in pre-mRNAs that undergo
alternative splicing (reviewed in Cáceres & Krainer,
1997)+ Exonic splicing enhancers (ESEs) are frequently
found in the exons downstream of the intron whose
splicing they influence (reviewed in Hertel et al+, 1997)+
The most studied class of ESE is composed of purine-
rich sequences (Lavigueur et al+, 1993; Sun et al+, 1993;
Watakabe et al+, 1993; Ramchatesingh et al+, 1995)+
The purine-rich ESEs are recognized by members of
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the SR protein family, a group of essential pre-mRNA
splicing factors with characteristic arginine/serine
C-terminal repeats (RS domain) and one or two RNA-
recognition motifs (Lavigueur et al+, 1993; Sun et al+,
1993; Staknis & Reed, 1994; Ramchatesingh et al+,
1995; Achsel & Shimura, 1996; Yeakley et al+, 1996)+
SR proteins help recognize weak splice sites and pro-
mote spliceosome assembly (Staknis & Reed, 1994) in
part through interactions with 39 splice-site compo-
nents (Wang et al+, 1995; Valcárcel et al+, 1996; Zuo &
Maniatis, 1996)+ Enhancer recognition and complex as-
sembly are sufficiently strong to promote trans-splicing
via 59 and 39 splice sites located on separate RNA
molecules (Bruzik & Maniatis, 1995; Chiara & Reed,
1995)+
Little is known about splice-site recognition and com-
mitment in the AT-AC pathway, other than the high con-
servation of sequence near the intron ends and the
base pairing with the low abundance U11, U12, and
U6atac snRNAs (reviewed in Nilsen, 1998)+ In the ma-
jor pathway, short exons often appear to be defined as
units prior to the pairing of splice sites, in a process
known as exon definition (reviewed in Berget, 1995)+
We showed previously that exon definition is also
relevant to the AT-AC splicing pathway; thus, a down-
stream conventional 59 splice site increases the effi-
ciency of AT-AC splicing, and this effect is dependent
on the integrity of the U1 snRNP (Wu & Krainer, 1996)+
In the present study, we show that purine-rich enhanc-
ers can promote AT-AC splicing as well, indicating that
the mechanisms of enhancer function and exon defi-
nition are compatible with the two different kinds of
components that are responsible for 39 splice site rec-
ognition in the conventional and the AT-AC splicing path-
ways+ The fact that U1, U2, U4, and U6 snRNAs are not
required for the basal AT-AC splicing reaction (Tarn &
Steitz, 1996a,b; Wu & Krainer, 1996, 1997) provides an
opportunity for investigating whether these snRNAs play
a role in enhancer function, as previously suggested
for the U1 snRNA (Watakabe et al+, 1993; Staknis &
Reed, 1994; Stark et al+, 1998)+ We have tested the
effects of cleavage, blockage, or depletion of the major
snRNAs on enhancer function and exon definition in
the context of AT-AC splicing+ The results reveal that
splicing stimulation by a downstream 59 splice site or by
a downstream ESE have a different mechanistic basis+
RESULTS AND DISCUSSION
Purine-rich enhancers stimulate AT-AC
pre-mRNA splicing in vitro
Exon definition and splicing enhancers are thought to
influence splicing efficiency by a very similar mecha-
nism (Watakabe et al+, 1993; Staknis & Reed, 1994;
Chiara & Reed, 1995; Wang et al+, 1995; Achsel &
Shimura, 1996)+ Both effects contribute to the selec-
tion of upstream splice sites and appear to involve
SR proteins (reviewed in Berget, 1995; Black, 1995;
Valcárcel et al+, 1995; Manley & Tacke, 1996; Cáceres
& Krainer, 1997)+ A downstream conventional 59 splice
site promotes splicing of the AT-AC intron 2 of the
voltage-gated skeletal muscle sodium channel a sub-
unit (SCN4A) pre-mRNA (Wu & Krainer, 1996)+ Purine-
rich enhancers have been shown to function with a
wide variety of substrates in the major splicing path-
way+ To determine whether they can also function in the
context of the AT-AC splicing pathway, we prepared
sodium channel pre-mRNA derivatives containing het-
erologous purine-rich enhancer elements, and com-
pared their splicing efficiencies to that of the parent
pre-mRNA (Fig+ 1A)+ The chosen motifs are present in
the natural enhancers previously identified in a wide
variety of cellular and viral genes (Fig+ 1B)+
The purine-rich sequences placed at the end of the
90-nt exon 3 greatly enhanced splicing of the AT-AC
intron 2 in HeLa cell nuclear extract (Fig+ 1A)+ The ba-
sal AT-AC splicing reaction with the SCN4AS substrate
(Wu & Krainer, 1997) is very weak (Fig+ 1A, lanes 1–4),
although the spliced products are visible in the longer
exposure (Fig+ 1A, bottom)+ As is commonly observed
with pre-mRNAs that splice inefficiently, there was con-
siderable RNA degradation during the incubation+ The
splicing stimulation by inclusion of the enhancer ele-
ments is not simply due to extending the length of the
downstream exon, because splicing of the SCN4AM
pre-mRNA, which also has an extension (GGAUCC
GAAUU), is not as efficient as in the presence of
the enhancers (data not shown and see below)+ The
enhancers stimulated AT-AC splicing to different ex-
tents (Fig+ 1A, lanes 5–8, 9–12, and 13–16)+ The
SCN4AENH1 pre-mRNA spliced most efficiently, sug-
gesting an additive effect between the two elements
in the bipartite enhancer+ Quantitation of the data
showed that the splicing efficiency of SCN4AENH1,
SCN4AENH2, and SCN4AENH3 pre-mRNAs increased
seven-, three-, and fourfold, respectively, compared to
the enhancerless SCN4AS pre-mRNA+ SCN4AENH1,
SCN4AENH2, and SCN4AENH3 pre-mRNAs spliced
more rapidly than SCN4AS pre-mRNA+ The AT-AC
spliced product is barely detectable in the case of the
SCN4AS pre-mRNA after 2+5 h of incubation, even in
the longer exposure+ In contrast, splicing can be readily
detected at this time point with the enhancer-containing
pre-mRNAs+ The enhancers also stimulated the previ-
ously described aberrant splicing reaction involving a
pair of cryptic conventional splice sites (Wu & Krainer,
1996)+ The stimulation of this pathway was even stron-
ger than that of the AT-AC pathway, perhaps because
the cryptic 39 splice site is closer to the enhancer
elements+
The catalytic core of the basal AT-AC spliceosome is
thought to be very similar to that of the major splice-
osome (Tarn & Steitz, 1996b; reviewed in Nilsen, 1996)+
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AT-AC pre-mRNA splicing requires the minor U11, U12,
U4atac, and U6atac snRNAs,which appear to play anal-
ogous roles to those of the major U1, U2, U4, and U6
snRNAs in the major splicing pathway (reviewed in
Nilsen, 1998)+ Exon definition and splicing enhancers
markedly affect both AT-AC and conventional splicing+
The SR proteins have been strongly implicated in
splicing enhancer recognition and function+ The three
heterologous enhancers used in this study include se-
quences present in the enhancers from a wide variety
of cellular genes, including IgM, hFN, bGH, doublesex,
cTNT, caldesmon, calcitonin/CGRP, b-TM, and hprt, as
well as of viral genes from ASLV, HIV, and EIAV, and
are also present in in-vitro-selected sequences that are
recognized by SR proteins (Tacke & Manley, 1995; Liu
et al+, 1998) (abbreviations are explained in the legend
FIGURE 1. Heterologous purine-rich exonic elements enhance AT-AC pre-mRNA splicing in vitro+ A: In vitro splicing time
course in Hela cell nuclear extract+ The SCN4AS pre-mRNA (lanes 1–4) is truncated at the end of exon 3+ The SCN4AENH1
(lanes 5–8), SCN4AENH2 (lanes 9–12), and SCN4AENH3 (lanes 13–16) pre-mRNAs have additional sequences following
exon 3, which are shown in B+ Capped, in vitro-transcribed, 32P-labeled pre-mRNAs were incubated under optimized
splicing conditions for the indicated times and analyzed by urea-PAGE and autoradiography+ The structure and electro-
phoretic mobilities of the pre-mRNAs and spliced mRNAs are indicated schematically on each side+ The solid black square
at the end of exon 3 indicates the placement of the heterologous purine-rich enhancers+ Aberrantly spliced mRNAs, arising
from use of conventional cryptic 59 and 39 splice sites (Wu & Krainer, 1996), are indicated by an asterisk+ A longer exposure
that shows the spliced products obtained with the SCN4AS pre-mRNA is shown at the bottom+ B: Nucleotide sequence of
the enhancer elements+ These sequences were joined to the 39 end of exon 3 of the voltage-gated skeletal muscle sodium
channel a subunit gene (SCN4A); the first 3 nt, GGA, are part of the natural 39 end of exon 3, and the distance to the
upstream 39 splice site is 87 nt+ Purines are shown in bold+ Two pyrimidines at the end of the transcripts derived from the
restriction site are also shown+ The motif introduced into the SCN4AENH2 pre-mRNA represents enhancer sequences
present in the following exons: the last membrane isoform-specific exon (M2) of mouse immunoglobin m (IgM) (Watakabe
et al+, 1993); exon 5 of bovine growth hormone (bGH) (Sun et al+, 1993); the last exon of avian sarcoma-leukosis virus
(ASLV) env protein (Katz & Skalka, 1990; Fu et al+, 1991); exon 3 of human hypoxanthine-guanine phosphoribosyltrans-
ferase (hprt) (Steingrimsdottir et al+, 1992); and exon 4 of Drosophila doublesex (Lynch & Maniatis, 1995)+ The SCN4AENH1
pre-mRNA has a bipartite enhancer+ The 59 portion of this enhancer is the same as the enhancer of the SCN4AENH2
pre-mRNA+ The 39 portion includes sequences present in the natural enhancers of the following exons: exon 5 of chicken
cardiac troponin T (cTNT) (Ramchatesingh et al+, 1995); exon 3 of the rat calcitonin/CGRP gene (Yeakley et al+, 1993); exon
EDIIIA of human fibronectin (hFN) (Mardon et al+, 1987; Lavigueur et al+, 1993); the second coding exon of human
immunodeficiency virus (HIV) tat-rev (Amendt et al+, 1995; Staffa & Cochrane, 1995); the ASLV env last exon; and exon 3
of equine infectious anemia virus (EIAV) tat/rev (Gontarek & Derse, 1996)+ The SCN4AENH3 pre-mRNA includes enhancer
sequences derived from the following exons: exon 3 of human hprt; exon EDIIIA of human FN; exon 5 of cTNT; exon 5 of
human caldesmon (Humphrey et al+, 1995); exon 8 of rat b-tropomyosin (TM) (Helfman et al+, 1988); second coding exon
of HIV tat-rev+
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to Fig+ 1)+ The natural enhancers from hFN (Lavigueur
et al+, 1993), bGH (Sun et al+, 1993), ASLV (Staknis &
Reed, 1994), doublesex (Lynch & Maniatis, 1995), cTNT
(Ramchatesingh et al+, 1995), EIAV (Gontarek & Derse,
1996), and calcitonin/CGRP (Yeakley et al+, 1996) have
been shown to interact specifically with SR proteins+
Exonic splicing enhancers are thought to facilitate 39
splice-site recognition by specific binding to SR pro-
teins, which in turn promote the binding of components
at the upstream 39 splice site through protein–protein
interactions (Wang et al+, 1995; Zuo & Maniatis, 1996)+
The finding that purine-rich enhancers function in both
minor and major splicing pathways suggests that at
least some of the functions of SR proteins are relevant
to the AT-AC splicing pathway+
Putative enhancer elements in natural
AT-AC pre-mRNA exons
Although we showed that purine-rich splicing enhanc-
ers can function in the context of an AT-AC intron, au-
thentic enhancers that naturally function in this context
remain to be identified+ We scanned the sequences of
the exons located immediately downstream of known
AT-AC introns (Wu & Krainer, 1997) and found one or
more purine-rich elements in several of these exons,
including exon 7 of the human P120 gene, exon 8 of
the human CMP gene, exon 7 of the human GT335
gene, exon 10 of the mouse CDK5 gene, exon 7 of the
mouse Rep-3 gene, exon 16 of the mouse HPS gene,
and exon 7 of a Xenopus TFIIS gene (data not shown)+
These purine runs are all located near the correspond-
ing upstream AT-AC 39 splice site (6–136 nt), well within
the previously established limit for enhancer function in
conventional splicing (;300 nt)(Lavigueur et al+, 1993;
Lynch & Maniatis, 1995)+ Several of these elements
match the sequences of known purine-rich enhancers
(Fig+ 1B), and therefore, at least some of them might
function as natural AT-AC splicing enhancers, although
this remains to be tested+ The SCN4A exon 3, present
in the substrates used in this study, lacks such a se-
quence, which is consistent with its strong response to
inclusion of a heterologous enhancer+ As with conven-
tional splicing enhancers, natural AT-AC splicing en-
hancers may be present at other exonic or intronic
locations, and they may not always be purine rich (Tian
& Maniatis, 1994; Tian & Kole, 1995; Coulter et al+,
1997; Liu et al+, 1998)+
Intact U1, U2, U4, and U6 snRNAs are not
required for purine-rich enhancer function
Whether the major spliceosomal snRNAs are involved
in splicing enhancement, that is, in recognition of purine-
rich enhancers or in bridging between enhancer-binding
factors and conserved intron elements, is difficult to
address rigorously in the context of the major splicing
pathway because of the requirement for these snRNAs
in the basal splicing reaction+ U1 snRNP has been
shown to play a role in exon definition in both the major
and minor splicing pathways, and it does so by binding
to the downstream conventional 59 splice site (Robber-
son et al+, 1990; Kuo et al+, 1991; Wu & Krainer, 1996)+
A role for an snRNA in enhancer recognition has pre-
viously been suggested in the case of U1 (Watakabe
et al+, 1993; Staknis & Reed, 1994; Stark et al+, 1998)+
Because the basal AT-AC splicing reaction does not
require the major snRNAs, except for the U5 snRNA,
nor is inactivation of the major pathway required in our
in vitro system, we have exploited these unique snRNA
requirements to investigate whether the snRNAs that
function exclusively in the conventional pathway are
required for enhancer function in the context of AT-AC
splicing+
We used oligonucleotide-directed RNase H cleavage
to inactivate the major snRNAs (Fig+ 2)+ U2-, U6-, or
U4-specific oligonucleotides did not inhibit SCN4AENH1
AT-AC splicing (Fig+ 2, lanes 1, 5–7, 11–13, and 17–
19)+ The same treatments likewise had no effect on
exon definition (Wu & Krainer, 1997)+ Cleavage of the
59 end of U1 snRNA did not inhibit SCN4AENH1 AT-AC
splicing (Fig+ 2, lanes 1–4), in contrast to the inhibition
of exon definition by the same treatment (Wu & Krainer,
1996)+ However, U1-, U2-, U4-, or U6-specific oligonu-
cleotides strongly inhibited splicing via the conven-
tional cryptic splice sites, providing useful internal
controls+ U12-, U6atac-, or U4atac-specific control oli-
gonucleotides completely inhibited SCN4AENH1 AT-AC
splicing, but had no inhibitory effect on the cryptic splic-
ing pathway, as expected (Fig+ 2, lanes 8–10, 14–16,
and 20–21)+ Very similar effects were obtained with the
SCN4AENH2 and SCN4AENH3 pre-mRNAs (data not
shown)+ In addition, different oligonucleotides comple-
mentary to other regions of U2, U4, and U6 snRNAs
gave the same inhibition profiles with these substrates+
We conclude that intact U1, U2, U4, and U6 snRNAs
are not required for splicing activation by purine-rich
enhancers+
Although U6 may be involved in exon definition
(Hwang & Cohen, 1996), cleavage of U6 snRNA does
not inhibit splicing of an AT-AC pre-mRNA with a con-
ventional downstream 59 splice site (Wu & Krainer,
1997)+ A role for U6 in this process may be more ap-
parent if the downstream 59 splice site has poor com-
plementarity to U1 snRNA (Tarn & Steitz, 1994;Crispino
& Sharp, 1995; Hwang & Cohen, 1996)+ Our previous
results suggested that U4 and U2 snRNAs are not re-
quired for exon definition+
Mechanistic difference between enhancer
function and exon definition
Cleavage of U2, U4, and U6 snRNAs does not inhibit
AT-AC splicing with either the SCN4AENH1 pre-mRNA,
Exonic enhancers stimulate AT-AC splicing 1667
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which has a heterologous enhancer, or with the SCN4A
pre-mRNA, which includes the downstream conven-
tional 59 splice site (Fig+ 2; Wu & Krainer, 1997)+ In
contrast, cleavage of the 59 terminus of U1 snRNA in-
hibits SCN4A AT-AC splicing (Wu & Krainer, 1996), but
has no effect on AT-AC splicing with the SCN4AENH1
pre-mRNA (Fig+ 2)+ This observation reveals a clear
difference between enhancer function and exon defini-
tion+ As shown above, enhancer function does not re-
quire the 59 terminus of U1 snRNA+ However, this does
not exclude a role for the rest of the U1 snRNP particle+
Previous studies showed that U1 snRNA lacking the
59 terminus can still function in splicing of chimeric pre-
mRNAs in which the 59 splice site region of an adeno-
virus major late pre-mRNA is replaced by spliced leader
sequences from Leptomonas collosoma or Caenorhab-
ditis elegans (Bruzik & Steitz, 1990; Seiwert & Steitz,
1993)+Antisense 29-O-methyl oligonucleotides comple-
mentary to the 59 terminus of U1 snRNA, which do not
confer sensitivity to RNase H, block U1 snRNP function
by a different mechanism—sequestration and/or steric
hindrance—and can thus uncover additional U1 func-
tions (Barabino et al+, 1990; Seiwert & Steitz, 1993)+
We used this approach to debilitate U1 snRNP in HeLa
nuclear extract (Fig+ 3)+ b-Globin splicing was strongly
inhibited (Fig+ 3, lanes 1–5)+ AT-AC splicing of the
SCN4A pre-mRNA was partially inhibited, reflecting a
loss of exon definition, while splicing via the cryptic
splice sites was completely inhibited (Fig+ 3, lanes 6–
10)+ These results are consistent with the inhibition of
SCN4AAT-AC splicing by RNase H cleavage of the U1
snRNA 59 end (Wu & Krainer, 1996)+ With the SCN4AM
pre-mRNA, basal AT-AC splicing was not inhibited, and
was in fact slightly stimulated, except at the highest
oligonucleotide concentration,while cryptic splicing was
inhibited (Fig+ 3, lanes 11–15)+ The stimulation proba-
bly results from inhibition of the competing splicing re-
action via the cryptic splice sites (Tarn & Steitz, 1996a;
Wu & Krainer, 1997)+ Finally, AT-AC splicing of the
enhancer-containing SCN4AENH1 pre-mRNA was
stimulated by U1 debilitation, while cryptic splicing was
completely inhibited (Fig+ 3, lanes 16–20)+ The same
29-O-methyl oligonucleotide had analogous effects
with the SCN4AS pre-mRNA (which lacks the down-
stream 59 splice site) and with the enhancer-containing
SCN4AENH2 and SCN4AENH3 pre-mRNAs (data not
shown)+ We conclude that exon definition is abrogated
when U1 snRNP is debilitated, whereas enhancer func-
tion is not inhibited+
To address the possibility that U1 snRNP particles
with a blocked U1 snRNA 59 terminus retain an activity
required for enhancer function, we depleted U1 snRNP
from nuclear extract using antisense affinity chroma-
tography with a biotinylated 29-O-methyl oligonucleo-
FIGURE 2. Purine-rich enhancer function does not require intact U1, U2, U4, or U6 major snRNAs+ The major or minor
spliceosomal snRNPs were inactivated by cleavage of their snRNA moieties with RNase H in the presence of complemen-
tary oligonucleotides+ The nuclear extract was preincubated under splicing conditions for 15 min in the absence (lane 1) or
presence of oligonucleotides specific for U1 (lanes 2–4), U2 (lanes 5–7), U12 (lanes 8–10), U6 (lanes 11–13), U6atac
(lanes 14–16), U4 (lanes 17–19) or U4atac (lanes 20–21)+ The final oligonucleotide concentration was 0+33 mM (lanes 2,
5, 8, 11, 14, 17, and 20), 1+31 mM (lanes 3, 6, 9, 12, 15, 18, and 21), or 5+25 mM (lanes 4, 7, 10, 13, 16, and 19)+ SCN4AENH1
pre-mRNA was added to each reaction and incubation was continued for 6 h+ Note that the exposure shown is shorter than
that in Figure 1, and that the preincubation step results in a slight decrease in splicing efficiency+
1668 Q. Wu and A.R. Krainer
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tide (Barabino et al+, 1990)+ In U1-depleted extracts,
the control b-globin splicing reaction was strongly in-
hibited, compared to mock-depleted extracts (Fig+ 4A,
lanes 1 and 2)+ The same treatment partially inhibited
SCN4A AT-AC splicing, and also inhibited splicing via
the cryptic splice sites (Fig+ 4A, lanes 3 and 4)+With the
SCN4AM pre-mRNA, AT-AC splicing was not inhibited,
and was in fact slightly stimulated—as it was in the
oligonucleotide inhibition experiments (Fig+ 3)—but splic-
ing via the cryptic conventional splice sites was inhib-
ited (Fig+ 4A, lanes 5 and 6)+ We note that SCN4A
pre-mRNA splicing in U1-depleted extracts was repro-
ducibly weaker than SCN4AM pre-mRNA splicing un-
der the same conditions (Fig+ 4A, lanes 3 and 5)+ This
difference suggests that residual U1 snRNP directs exon
definition with the SCN4A pre-mRNA, but does so poorly,
whereas the SCN4AM pre-mRNA, which lacks the U1
binding site, is spliced via intron definition+ Finally,
SCN4AENH1 cryptic splicing was completely inhibited
in the U1-depleted extracts, but AT-AC splicing was
unaffected, compared to the mock-treated extract
(Fig+ 4A, lanes 7 and 8)+ These results once again
reveal a difference in the requirement for U1 snRNP
between enhancer function and exon definition+
Six sets of independent AT-AC splicing reactions were
carried out using U1-depleted and mock-depleted ex-
tracts, and the resulting splicing efficiencies were
measured (Fig+ 4B)+ The strong inhibition of b-globin in
U1-depleted versus mock-depleted extracts was repro-
ducibly observed, and a statistically significant twofold
reduction in SCN4A pre-mRNAAT-AC splicing was also
seen+ U1 depletion had no significant effect on AT-AC
splicing in the absence of a wild-type downstream 59
splice site (SCN4AM pre-mRNA) or in the presence of
an enhancer (SCN4AENH1 pre-mRNA)+ Northern blot-
ting with a U1-specific probe and a control U2-specific
probe showed specific and extensive depletion of U1
snRNA (Fig+ 4C, lanes 1 and 2)+ We do not know if the
residual levels of b-globin splicing result from the trace
levels of remaining U1 snRNP, or represent inefficient
splicing via a previously proposed U1-independent path-
way (Crispino et al+, 1994; Tarn & Steitz, 1994)+
Purine-rich enhancers stimulate AT-AC
splicing independently of U1 snRNP
U1 snRNA was the first component shown to bind to
vertebrate exonic splicing enhancers (Watakabe et al+,
1993; Staknis & Reed, 1994; Stark et al+, 1998; re-
viewed in Valcárcel et al+, 1995;Manley & Tacke, 1996)+
The 59 terminus of U1 snRNA was crosslinked to the
IgM exon 2 purine-rich enhancer, suggesting that U1
snRNP may recognize enhancers by base pairing (Wa-
takabe et al+, 1993)+ U1 is also present in a complex
assembled on an ASLV RNA containing an enhancer
(Staknis & Reed, 1994)+ Finally, RNA affinity chroma-
tography of an S100 extract with an enhancer-containing
cTNT exon resulted in binding of U1 snRNA; this bind-
ing was stimulated by SR proteins and was largely
dependent on the 59 terminus of U1 (Stark et al+, 1998)+
These studies suggested that U1 plays a role in en-
hancer recognition and/or function+
FIGURE 3. Effect of U1 snRNP debilitation on conventional and AT-AC splicing, exon definition, and enhancer function+
Nuclear extract was preincubated in the absence (lanes 1, 6, 11, and 16) or presence (lanes 2–5, 7–10, 12–15, and 17–20)
of a U1-specific 29-O-methyl oligonucleotide at a final concentration of 2+63 mM (lanes 2, 7, 12, and 17), 5+25 mM (lanes 3,
8, 13, and 18), 10+5 mM (lanes 4, 9, 14, and 19), or 21+0 mM (lanes 5, 10, 15, and 20) under splicing conditions for 10 min+
b-Globin (lanes 1–5), SCN4A (which has an AT-AC intron and includes the downstream conventional 59 splice site;
lanes 6–10), SCN4AM (which has a mutant downstream 59 splice site; lanes 11–15), or SCN4AENH1 pre-mRNA (which has
a heterologous enhancer; lanes 16–20), was added and the reactions were further incubated for 6 h+
Exonic enhancers stimulate AT-AC splicing 1669
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The proposed mechanisms of exon definition and
enhancer function are closely related (Staknis & Reed,
1994; Berget, 1995; Wang et al+, 1995)+ Both pro-
cesses facilitate spliceosome assembly around short
exons and involve bridging via SR proteins to compo-
nents bound at the 39 splice site+ SR proteins have
been shown to promote binding of U1 snRNP to 59
splice sites (Eperon et al+, 1993; Kohtz et al+, 1994;
Zahler & Roth, 1995)+ In exon definition, U1 stimulates
splicing of major or minor upstream introns by base
pairing to the downstream 59 splice site and interacting—
presumably indirectly—with U2 or U12 snRNPs across
the exon+ SR proteins bound to purine-rich enhancers
may also recruit U1 snRNP (reviewed in Valcárcel
et al+, 1995; Manley & Tacke, 1996; Cáceres & Krainer,
1997)+ However, whether U1 plays a role in the rec-
ognition or function of splicing enhancers remains
controversial+ Mutational analysis and competition ex-
periments did not support a mechanism involving di-
rect base pairing between the IgM enhancer and U1
snRNA, suggesting that U1 may only have an indirect
general stimulatory effect on enhancer-mediated splic-
ing (Tanaka et al+, 1994)+ Other experiments suggested
that U1 is not required for the function of a purine-rich
enhancer in ASLV (Achsel & Shimura, 1996)+ It has
also been shown that the U1 59 terminus is not required
for the enhancer-mediated stimulation of U2AF binding
to the upstream polypyrimidine tract (Wang et al+, 1995)+
Here we present functional evidence that purine-rich
enhancers stimulate AT-AC splicing independently of
U1 snRNP, suggesting that there is no intrinsic require-
ment for U1 in enhancer function in either the major or
minor pathway+ First, cleavage of the 59 terminus of U1
snRNA by RNase H does not inhibit enhancer function
(Fig+ 2)+ Second, to address the possibility that U1 par-
ticipates in enhancer function other than by base pair-
ing interactions mediated by its 59 end, U1 snRNP was
inactivated by binding of a complementary 29-O-methyl
oligonucleotide+Previous studies showed that U1 snRNA
lacking the 59 terminus can still function in splicing of
spliced leader and adenovirus major late chimeric pre-
mRNAs (Bruzik & Steitz, 1990)+ This particular function
of U1 is resistant to RNase H-mediated inactivation but
is sensitive to treatment with a 29-O-methyl oligonucle-
otide (Seiwert & Steitz, 1993)+ In contrast, we found
that treatment with this oligonucleotide does not inhibit
SCN4AENH1 AT-AC splicing (Fig+ 3)+ Finally, we de-
pleted U1 snRNP from nuclear extract by affinity chro-
matography with an antisense oligonucleotide, and
found that exonic enhancers remained functional in the
U1-depleted extract (Fig+ 4)+ Because this treatment
severely compromised b-globin splicing, exon defini-
tion, and sodium channel pre-mRNA splicing via con-
ventional cryptic splice sites, it seems unlikely that the
trace amounts of remaining U1 are sufficient to allow
efficient U1-dependent enhancer function+ The deple-
tion method probably does not remove U1 particles
devoid of the U1 59 terminus (U1*)+ U1* is thought to
arise in vitro (Lerner et al+, 1980) and is not functional
in spliceosome assembly (D+A+ Wassarman & Steitz,
1993)+ It is difficult to rule out the possibility that trace
amounts of U1* participate in enhancer function+ How-
ever, it was recently reported that SR proteins promote
binding of U1* snRNA to an enhancer-containing RNA
much less efficiently than they do in the case of intact
U1 snRNA (Stark et al+, 1998)+ Taken together, the re-
sults of U1 cleavage, debilitation, and depletion strongly
suggest that purine-rich enhancers function indepen-
dently of U1 snRNP+
The previously noted binding of U1 snRNP at or near
certain enhancer elements may be fortuitous or per-
FIGURE 4. Effect of U1 snRNP depletion+ A: Splicing of b-globin
(lanes 1 and 2), SCN4A (lanes 3 and 4), SCN4AM (lanes 5 and 6),
and SCN4AENH1 (lanes 7 and 8) pre-mRNAs in U1-depleted nu-
clear extract (lanes 1, 3, 5, and 7) or mock-depleted nuclear extract
(lanes 2, 4, 6, and 8)+ B: Quantitation of splicing efficiencies in U1-
depleted extracts+ Six sets of splicing reactions were carried out for
each AT-AC pre-mRNA, as in A, with U1-depleted extracts (black
bars) and mock-depleted extracts (white bars)+ The b-globin pre-
mRNA control was done twice+ Splicing efficiency was normalized to
the level obtained for each pre-mRNA in mock-depleted extract,which
was set at 100%+ C: Extent of depletion of U1 snRNP+ Northern blot
of U1-depleted extract (lane 1) and mock-depleted extract (lane 2)
using U1- and U2-specific probes+
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haps related to a process other than splicing enhance-
ment+ We note that both the IgM and ASLV enhancers,
for which U1 binding under splicing conditions was re-
ported, are located in 39-terminal exons+ Therefore, we
favor the idea that U1 binding at 39 terminal exons
reflects the interplay between 39-end processing and
splicing of the last intron, that is, definition of the last
exon (K+M+ Wassarman & Steitz, 1993; Furth et al+,
1994; Lou et al+, 1996)+ It has also been proposed that
U1 binding to the last exon may play a role in mRNA
transport (K+M+ Wassarman & Steitz, 1993)+ It remains
formally possible that U1 plays a role in splicing en-
hancement in the context of the conventional pathway,
or that it is required for the function of some enhancers
but not others, depending on the sequence context+
Implications for splicing mechanisms
We have demonstrated that heterologous purine-rich
enhancers can promote sodium channel AT-AC pre-
mRNA splicing in vitro+ We described the existence of
natural purine-rich sequences, some of which may func-
tion as splicing enhancers, in the exons downstream of
several AT-AC introns+ We further showed that exon
definition and enhancer function have different U1
snRNP requirements+ In exon definition, the down-
stream 59 splice site apparently communicates with com-
ponents bound at the upstream 39 splice site, by means
of base pairing with U1 snRNA and bridging via SR
proteins+ In the case of enhancers, SR proteins can
directly bind to the enhancers and promote assembly
of components at the 39 splice site+ In the major path-
way, SR proteins are thought to stabilize the binding of
U2AF to the polypyrimidine tract of the upstream 39
splice site by contacting U2AF35 ; U2AF65 in turn pro-
motes binding of U2 snRNA to the adjacent branch
site+ Whether AT-AC splicing requires one or both sub-
units of U2AF, or whether it utilizes an analogous
but distinct component, is not known+ However, this
presumptive component is expected to interact with
complexes formed at exonic enhancers and/or at down-
stream conventional 59 splice sites+ We have been un-
able to reconstitute AT-AC splicing by complementation
of U2AF-depleted extracts with active U2AF65, appar-
ently because a component(s) specific for AT-AC splic-
ing is inactivated by the depletion procedure (data not
shown); therefore, whether or not U2AF65 itself is in-
volved in AT-AC splicing remains an open question+
Considering the obvious differences in the 39 splice
site elements and sequence context between AT-AC
and conventional introns, it is remarkable that the same
enhancers can function in AT-AC splicing as well+Given
the absence of a polypyrimidine tract, the lack of a
requirement for U2 snRNA, and the short distance be-
tween the branch and the 39 splice site, it is conceiv-
able that SR proteins instead contact a component of
the U11/U12 di-snRNP to facilitate U12 snRNA binding
to the branch site+ Further insights into AT-AC pre-
mRNA splicing mechanisms await the identification of
snRNP and non-snRNP protein components of this
pathway+
MATERIALS AND METHODS
Plasmid constructions
A fragment containing exon 2, intron 2, and exon 3 of SCN4A
was amplified from the pSP64-SCN4A plasmid DNA using a
forward primer with a Hind III site and a reverse primer with
an EcoR I site and the SCN4AENH1 enhancer sequence
(Fig+ 1B)+ This fragment was digested with Hind III and
EcoR I and subcloned into the corresponding sites of pSP64
(Promega) to generate the pSP64-SCN4AENH12 plasmid+ A
similar fragment was amplified using the same forward primer
and a different reverse primer with a BamH I site and the
SCN4AENH3 enhancer sequence (Fig+ 1B)+ This fragment
was digested with Hind III and BamH I and subcloned into
pSP64 to generate the pSP64-SCN4AENH3 plasmid+ Both
constructs were confirmed by sequence analysis+ pSP64-
SCN4AENH12 was linearized with EcoR I or BamH I and
pSP64ENH3 was linearized with BamH I for use as tem-
plates for in vitro transcription with SP6 RNA polymerase
to generate pre-mRNA splicing substrates SCN4AENH1,
SCN4AENH2, and SCN4AENH3, respectively+ The transcripts
contain short extensions at both ends, derived from the re-
striction site or vector+ The pSP64-SCN4A, pSP64-SCN4AM,
and pSP64-SCN4AS plasmids have been described (Wu &
Krainer, 1996, 1997)+
In vitro splicing assays and
inhibition experiments
Nuclear extract and substrate preparation, and conditions for
in vitro splicing in Figures 1 and 2 were as described (Wu &
Krainer, 1996), with the incubation times indicated in the fig-
ures or legends+ Slight changes in reaction conditions result
in optimal AT-AC splicing with different extract batches+ In
Figures 3 and 4, we used 5+5 mM MgCl2, 2+5 mM ATP, and
40 mM creatine phosphate, which resulted in more efficient
basalAT-AC splicing than reported previously+Oligonucleotide-
directed RNase H cleavage experiments and the oligonucle-
otides sequences were as described (Wu & Krainer, 1997)+
29-O-methyl oligonucleotide inhibition experiments were per-
formed as described (Wu & Krainer, 1997) using a 29-O-
methyl oligonucleotide (Oligos Etc+, Inc+) complementary to
U1 snRNA position 1–14+ All experiments were performed at
least twice with similar results+
U1 snRNP depletion and northern blotting
U1 snRNP depletion was performed by modification of a
published protocol (Barabino et al+, 1990), using a biotinyl-
ated 29-O-methyl oligonucleotide complementary to U1 snRNA
position 1–14 followed at the 39 end with 4 biotin-dU resi-
dues+ Splicing extract was used instead of undialyzed nu-
clear lysate, NP-40 was omitted, and the oligonucleotide
concentration was 7+5 mM+ Nuclear extract was incubated for
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30 min at 30 8C with the biotinylated oligonucleotide and added
to an equal volume of streptavidin-agarose beads (Sigma)
that had been pre-blocked as described (Barabino et al+, 1990)
and washed with extract dialysis buffer+ The suspension was
rocked in the cold room for 45 min and the supernatant was
incubated again with an equal volume of fresh streptavidin-
agarose beads+ For mock depletion, the extract was treated
in the same manner, except that the oligonucleotide was omit-
ted+ Further batch treatment with streptavidin-agarose to
achieve more extensive U1 depletion resulted in nonspecific
inhibition of splicing (data not shown)+ RNA was extracted
and analyzed by Northern blotting with U1- and U2-specific
RNA probes (Konarska & Sharp, 1987) transcribed from plas-
mids kindly provided by M+ Konarska+
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